<p>Postherpetic neuralgia is a common complication of shingles caused by varicella-zoster virus (VZV) reactivation, which resides latently in the body after a primary varicella infection. The shingles outbreak causes damage to the sensory nerves, which leads to abnormal signals being sent to the brain, resulting in pain. Postherpetic neuralgia is a neuropathic pain syndrome characterized by pain that persists for more than 90 days after the outbreak of herpes zoster. Common symptoms experienced by patients with postherpetic neuralgia include burning, stabbing, shooting, aching, throbbing, itching, or electric shocks on the affected area. Risk factors for postherpetic neuralgia are increasing age and immunosuppression. People who have acute pain and severe rash during shingles also have a higher risk of developing postherpetic neuralgia.</p>
<h2><strong>Postherpetic Neuralgia Epidemiological Segmentation</strong></h2>
<p>The Epidemiological Segmentation of Postherpetic Neuralgia in 7MM from 2020 to 2034 is segmented as:-</p>
<ul>
<li>Total Incident Cases Of Herpes Zoster</li>
<li>Total Postherpetic Neuralgia Incident Cases</li>
<li>Postherpetic Neuralgia Gender-specific Cases</li>
<li>Postherpetic Neuralgia Age-specific Cases</li>
<li>Total Postherpetic Neuralgia Treated Cases</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/postherpetic-neuralgia-epidemiology-forecast"><span style="text-decoration: underline;"><strong>Postherpetic Neuralgia Epidemiology</strong></span></a></h2>
<ul>
<li>In 2023, incident cases of herpes zoster in the 7MM were approximately 4 million, projected to increase due to an aging population and increased use of immunosuppressive therapies.</li>
<li>Postherpetic Neuralgia (PHN) incident cases in the 7MM totaled around 600,000 in 2023, with expected growth by 2034.</li>
<li>The US accounted for the highest number of PHN cases in the 7MM, with approximately 300,000 cases in 2023.</li>
<li>PHN is slightly more common in females, accounting for around 60% of cases, while males represent 40% of the total.</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/postherpetic-neuralgia-market"><span style="text-decoration: underline;"><strong>Postherpetic Neuralgia Market</strong></span></a></h2>
<p>The Postherpetic Neuralgia market size in the 7MM was ~USD 100 Million in 2023.</p>
<h2>Postherpetic Neuralgia Market Drivers:</h2>
<ul>
<li>ZTlido offers multiple advantages over existing lidocaine patches, such as superior bioavailability, better adhesion, and more efficient drug delivery, enhancing its uptake and offering a competitive edge in the market.</li>
<li>&nbsp;Growing awareness of the significant impact of Herpes Zoster and PHN on quality of life can lead to improved prevention and management strategies, expanding the market for PHN treatments.</li>
</ul>
<h2>Postherpetic Neuralgia Market Barriers:</h2>
<ul>
<li>Despite treatment advancements, the exact mechanism of PHN remains unclear, and the efficacy of existing treatments is often unsatisfactory, limiting therapeutic options and market growth.</li>
<li>ZTlido faces potential competition from generic lidocaine patches from manufacturers like Mylan, Teva Pharmaceutical, Par Pharmaceutical, and LIDODERM, which may limit its market share.</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/postherpetic-neuralgia-pipeline-insight"><span style="text-decoration: underline;"><strong>Postherpetic Neuralgia Emerging Drugs</strong></span></a></h2>
<ul>
<li>LX9211</li>
<li>Incobotulinum toxin A</li>
</ul>
<p>And others.&nbsp;</p>
<h2><a href="https://www.delveinsight.com/report-store/postherpetic-neuralgia-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape"><span style="text-decoration: underline;"><strong>Postherpetic Neuralgia Key Players</strong></span></a></h2>
<ul>
<li>Lexicon Pharmaceuticals</li>
<li>Merz Therapeutics</li>
</ul>
<p>And others.</p>

Postherpetic Neuralgia Market Infographic

Postherpetic Neuralgia Market Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.